TANG PRIZE/Tang Prize laureate happy his research may save COVID-19 patients
06/19/2020 10:43 PM
Japanese immunologist Kishimoto Tadamitsu, one of the co-winners of the 2020 Tang Prize in biopharmaceutical science, was very happy that his early research has shown potential in saving COVID-19 patients from dying due to complications.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in TANG PRIZE
- Drugs treating diabetes, obesity can do more: Tang Prize laureatesSvetlana Mojsov and Jens Juul Holst, two of the laureates of the 2024 Tang Prize in Biopharmaceutical Science, said at a forum in Taichung on Tuesday that the GLP-1-based drugs their research spawned could go beyond managing diabetes and obesity.10/01/2024 08:52 PM
- Tang Prize winner lauds Taiwan implementation of human rights covenantsFormer Irish President Mary Robinson on Monday praised Taiwan's efforts to incorporate international covenants on human rights into its domestic law despite not being a signatory.09/30/2024 08:58 PM
- Historian shares research into ancient Chinese myth at Tang Prize forumRenowned Taiwanese-American historian Hsu Cho-yun (許倬雲) on Monday said his work regarding the ancient Chinese myth Da Yu (大禹) was a successful example of integrating social science methodologies into historical research that helped him win the 2024 Tang Prize in Sinology.09/30/2024 01:52 PM
Latest
- Society
Cabinet approves draft of Youth Basic Law
05/01/2025 05:01 PM - Society
Labor Day march calls for improved working conditions
05/01/2025 04:40 PM - Society
Murder charge dropped in case of teenage millionaire's death
05/01/2025 04:29 PM - Business
3 firms enforce furloughs due to U.S. tariff impact
05/01/2025 03:52 PM - Politics
Cabinet approves draft amendment to extend tax rebates for appliances
05/01/2025 03:37 PM